SOUTH SAN FRANCISCO, Calif., December 05, 2024--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic ...
Source LinkSOUTH SAN FRANCISCO, Calif., December 05, 2024--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic ...
Source Link
Comments